About this trial
It is recommended to focus on the physical functionality, chewing, and swallowing performance of individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evaluate them on a biopsychosocial basis to support their disease management. The aim was to assess the biopsychosocial characteristics of both children and adults diagnosed with scleroderma and to examine their chewing and swallowing performance.
Additionally, this study aims to identify effective scales that can be used in future research to assess chewing and swallowing in individuals diagnosed with scleroderma.
Eligibility criteria
Qualifiers
Cases diagnosed with scleroderma,
Cases aged 7-18 years will be included.
Disqualifiers
Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
Cases that are not willing to participate in the study will be excluded.
Having participated in a regular exercise program for the past 3 months
Individuals who are not willing to participate in the study
Trial design
Treatments tested in this trial
- Questionnaire application for child and adult scleroderma patients